EP1.18-19 Patients with Unresectable Stage III Non-Small Cell Lung Cancer Eligible to Receive Durvalumab in Clinical Practice

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 14; no. 10; p. S1103
Main Authors Furuhashi, K., Hataji, O., Nakamura, Y., Suzuki, Y., Sakaguchi, T., Ito, K., Fujiwara, K., Nishii, Y., Taguchi, O.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2019.08.2464